Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
10,417 results
- Salt to GrowIndependent statistical analysis of Physiologic Approach to Sodium Supplementation in Premature Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03889197).
- SAMIndependent statistical analysis of Sensory Augmentation Methods in Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03988400).
- SAMMPRISIndependent statistical analysis of Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) Trial: Complete Statistical AnalysisIndependent statistical analysis of Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01178827).
- SANDPIPERIndependent statistical analysis of A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase…
- SANICSIIIndependent statistical analysis of SANICS II Trial: Stimulation of the Autonomic Nervous System in Colorectal Surgery by Perioperative Nutrition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly: Complete Statistical AnalysisIndependent statistical analysis of Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03312231).
- Sanofi H1N1 + TIV – Adults and Elderly: Complete Statistical AnalysisIndependent statistical analysis of Sanofi H1N1 + TIV - Adults and Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00943878).
- SAPHEIndependent statistical analysis of Somatuline Autogel Preference and Health Economy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00681187).
- SAPPHIREIndependent statistical analysis of Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SAPPHIRE PhAIndependent statistical analysis of SEARCH SAPPHIRE Phase A: A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Saracatinib and Alcohol Drinking: Complete Statistical AnalysisIndependent statistical analysis of Saracatinib and Alcohol Drinking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02955186).
- Saracatinib in Treating Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Saracatinib in Treating Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01267266).
- Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SARCAIndependent statistical analysis of Lansoprazole to Treat Children With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00442013).
- Sarizotan in Participants With Parkinson’s Disease Suffering From Treatment Associated Dyskinesia: Complete Statistical AnalysisIndependent statistical analysis of Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SARONAPLUSIndependent statistical analysis of Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SARS-CoV-2 Human Challenge Characterisation Study: Complete Statistical AnalysisIndependent statistical analysis of SARS-CoV-2 Human Challenge Characterisation Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04865237).
- SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation: Complete Statistical AnalysisIndependent statistical analysis of SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04631705).
- SAT1Independent statistical analysis of University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SAT2HIV-IIIndependent statistical analysis of The Substance Abuse Treatment to HIV Care II (SAT2HIV-II) Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04687917).
- Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Satisfaction of Treatment Among Elderly Patients With Insulin Therapy: Complete Statistical AnalysisIndependent statistical analysis of Satisfaction of Treatment Among Elderly Patients With Insulin Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01240200).
- SaVEIndependent statistical analysis of Utilizing Text Messaging to Improve Vehicle Safety Among At-Risk Young Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Savella in Treatment for Provoked Vestibulodynia: Complete Statistical AnalysisIndependent statistical analysis of Savella in Treatment for Provoked Vestibulodynia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01304589).
- SAXAPCOSIndependent statistical analysis of Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SayLipIndependent statistical analysis of Study to Evaluate the Effectiveness, Safety and Long Term Safety of Saypha® FILLER Lidocaine for Lip Augmentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SayWhenIndependent statistical analysis of Better Than Study: Targeting Heavy Alcohol Use With Naltrexone Among Men Who Have Sex With Men (MSM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SBIndependent statistical analysis of An Evaluation of Rigid Sternal Fixation in Supporting Bone Healing and Improving Postoperative Recovery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SBIRT-PTSDIndependent statistical analysis of Evaluation and Treatment of Substance Abuse in Veterans With PTSD Disability Claims: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SBRTvsTACEIndependent statistical analysis of Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Conversational Agent Study: Complete Statistical AnalysisIndependent statistical analysis of SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Conversational Agent Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers: Complete Statistical AnalysisIndependent statistical analysis of SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Testing Among Utah Community Health Centers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SCALPIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp: primary endpoint results, effect…
- ScanBritIndependent statistical analysis of ScanBrit Dietary Intervention in Autism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00614198).
- SCANREP: Reliability of 3D Lower Limb Scanning: Complete Statistical AnalysisIndependent statistical analysis of SCANREP: Reliability of 3D Lower Limb Scanning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04032041).
- Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment: Complete Statistical AnalysisIndependent statistical analysis of Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05618912).
- SCD PED-02Independent statistical analysis of A Multi-Center Study of a SCD for Immunomodulatory Dysregulation in Pediatric AKI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SCENT2Independent statistical analysis of Smell in Covid-19 and Efficacy of Nasal Theophylline: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04789499).
- SCH 54031 PEG12000 Interferon Alfa-2b (PEG Intron, MK-4031) vs. INTRON®A (SCH 30500, MK-2958) as Adjuvant Therapy for Melanoma (C98-135, MK-4031-002): Complete Statistical AnalysisIndependent statistical analysis of SCH 54031 PEG12000 Interferon Alfa-2b (PEG Intron, MK-4031) vs. INTRON®A (SCH 30500, MK-2958) as Adjuvant Therapy for Melanoma (C98-135, MK-4031-002): primary endpoint results, effect estimate with confidence interval,…
- School-Based Mental Health Effectiveness Study: Complete Statistical AnalysisIndependent statistical analysis of School-Based Mental Health Effectiveness Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04383327).
- SCI Acute Intermittent Hypoxia and Non-Invasive Spinal Stimulation Combined With Gait Training: Complete Statistical AnalysisIndependent statistical analysis of SCI Acute Intermittent Hypoxia and Non-Invasive Spinal Stimulation Combined With Gait Training: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SCIENCEIndependent statistical analysis of Spinal Cord Injury Exercise and Nutrition Conceptual Engagement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03495986).
- SCIPHSIndependent statistical analysis of Impact of Passive Heat on Metabolic, Inflammatory and Vascular Health in Persons With Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SCITMOIndependent statistical analysis of Subcutaneous Immunotherapy for Mouse in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02532179).
- SclerodermaIndependent statistical analysis of Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02530996).
- SCNSL1Independent statistical analysis of High-dose Sequential Chemoimmunotherapy for B-cell Lymphomas With Central Nervous System Involvement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SCORPIOComplete statistical analysis of the SCORPIO phase 3 trial of mirabegron in patients with symptoms of overactive bladder, including endpoint definitions, ANCOVA methodology, efficacy results, multiplicity, missing-data handling, and safety.
- ScorpioNRGPSIndependent statistical analysis of Scorpio Posterior Stabilised (PS) vs Scorpio NRG ("Energize") PS - Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…